Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 17:1:100004.
doi: 10.1016/j.dadr.2021.100004. eCollection 2021 Dec.

Alcohol use disorder treatment and outcomes among hospitalized adults with alcoholic hepatitis

Adam C Winters  1 , Folasade P May  1   2   3 , Yun Wang  1 , Paul Shao  3 , Liu Yang  1 , Arpan A Patel  1   2
Affiliations

Alcohol use disorder treatment and outcomes among hospitalized adults with alcoholic hepatitis

Adam C Winters et al. Drug Alcohol Depend Rep. .

Abstract

Purpose: : The burden of alcohol-associated liver disease (ALD) in the United States (US) has continued to worsen in the background of rising rates of alcohol use disorder. Patients with ALD present to care at a late stage, often with the sequela of liver decompensation, such as gastrointestinal bleeding and infection. ALD is now the leading indication for liver transplantation. We aimed to measure the quality of care delivered to hospitalized patients with alcoholic hepatitis (AH) across 3 domains: 1) alcohol-use disorder (AUD) care, 2) inpatient cirrhosis care, and 3) alcohol-associated liver disease (ALD) care-and observe associations between quality of care and outcomes.

Methods: : We included hospital encounters between January 1, 2016 and January 1, 2019 to a large, diverse integrated health system for AH with active alcohol use within the prior 60 days. The diagnosis of AH was determined based on previously published clinical and laboratory criteria. Quality indicator (QI) pass rates were calculated as the proportion of patients eligible for each indicator who received the QI within the timeframe specified. We then evaluated the association between the receipt of all QIs and 6-month mortality, as well as AUD-specific QIs and 30-day readmission.

Results: : Of the 179 patients, the median age was 47 years-old, 59.2% were male and 49.2% were non-Hispanic White. The median Model for End-Stage Liver Disease-Sodium score was 25, while the median discriminant function was 33. Patients were followed for an average of 21 months. Overall, 14% of patients died during the index hospitalization while 17.3% died following discharge and 24.8% were re-admitted within 30-days. QI pass-rates were variable across the different domains. Few patients received AUD care-pass rates for receipt of pharmacotherapy and behavioral therapy at 6 months were only 19.1% and 35.1%, respectively. There was a significant association between receiving behavioral therapy and 6-month mortality-3% vs 18%, p = 0.05.

Conclusion: : The quality of care received during hospital encounters for AH is variable, and AUD-specific therapy is low. Future quality of care initiatives are warranted to link patients to AUD treatment to ensure optimal care and maximize patients survival in this at-risk population.

Keywords: Alcohol-associated liver disease; Alcohol-use disorder; Alcoholic hepatitis.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

Figures

Fig. 1:
Fig. 1
Study population with exclusion criteria.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Addolorato G., Leggio L., Ferrulli A., Cardone S., Vonghia L., Mirijello A., Abenavoli L., D'Angelo C., Caputo F., Zambon A., Haber P.S., Gasbarrini G. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet. 2007, Dec 8;370(9603) doi: 10.1016/S0140-6736(07)61814-5. 1915-1922. - DOI - PubMed
    1. Bazzi A., Saitz R. Screening for unhealthy alcohol use. JAMA. 2018, Nov 13;320(18):1869–1871. doi: 10.1001/jama.2018.16069. - DOI - PMC - PubMed
    1. Cargill, Z., Kattiparambil, S., Hansi, N., Barnabas, A., Shawcross, D.L., Williams, R., & Agarwal, K. (2020). Severe alcohol-related liver disease admissions post-COVID-19 lockdown: canary in the coal mine?Frontline Gastroenterol., flgastro-2020-101693. https://doi.org/10.1136/flgastro-2020-101693. - PMC - PubMed
    1. Cholankeril, G., Ahmed, A. (2018, Aug). Alcoholic liver disease replaces hepatitis C virus infection as the leading indication for liver transplantation in the United States. Clin. Gastroenterol. Hepatol., 16 (8), 1356–1358. https://doi.org/10.1016/j.cgh.2017.11.045. - PMC - PubMed
    1. Crabb D.W., Bataller R., Chalasani N.P., Kamath P.S., Lucey M., Mathurin P., McClain C., McCullough A., Mitchell M.C., Morgan T.R., Nagy L., Radaeva S., Sanyal A., Shah V., Szabo G., Consortia N.A.H. Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA alcoholic hepatitis consortia. Gastroenterology. 2016, Apr;150(4):785–790. doi: 10.1053/j.gastro.2016.02.042. - DOI - PMC - PubMed